Evaluation of Medication Exposure on Exacerbation of Disease in Patients With Myasthenia Gravis.

Nick Petrucelli Megan E BarraJennifer L Koehl

Published in: The Neurohospitalist (2023)

Of the medications reported to potentially worsen MG, intravenous labetalol and intravenous magnesium were the 2 agents associated with myasthenic exacerbations with a higher incidence in patients harboring additional risk factors.

Keyphrases

risk factors
chronic obstructive pulmonary disease
myasthenia gravis
ejection fraction
high dose
newly diagnosed
healthcare
cystic fibrosis
intensive care unit
adverse drug